X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with Wockhardt - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs WOCKHARDT LTD. - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

WOCKHARDT LTD. 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD WOCKHARDT LTD. STRIDES SHASUN LTD/
WOCKHARDT LTD.
 
P/E (TTM) x 14.0 16.7 83.7% View Chart
P/BV x 1.9 1.7 111.1% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 STRIDES SHASUN LTD   WOCKHARDT LTD.
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-16
WOCKHARDT LTD.
Mar-16
STRIDES SHASUN LTD/
WOCKHARDT LTD.
5-Yr Chart
Click to enlarge
High Rs1,4132,000 70.6%   
Low Rs848706 120.1%   
Sales per share (Unadj.) Rs353.3403.7 87.5%  
Earnings per share (Unadj.) Rs23.429.5 79.4%  
Cash flow per share (Unadj.) Rs41.042.4 96.7%  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs320.4323.4 99.1%  
Shares outstanding (eoy) m89.35110.51 80.9%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x3.23.4 95.5%   
Avg P/E ratio x48.345.9 105.3%  
P/CF ratio (eoy) x27.631.9 86.4%  
Price / Book Value ratio x3.54.2 84.3%  
Dividend payout %21.40-   
Avg Mkt Cap Rs m100,988149,509 67.5%   
No. of employees `0004.77.4 63.6%   
Total wages/salary Rs m4,9889,443 52.8%   
Avg. sales/employee Rs Th6,730.06,048.6 111.3%   
Avg. wages/employee Rs Th1,063.61,280.2 83.1%   
Avg. net profit/employee Rs Th445.5441.5 100.9%   
INCOME DATA
Net Sales Rs m31,56444,614 70.7%  
Other income Rs m1,212970 125.0%   
Total revenues Rs m32,77645,584 71.9%   
Gross profit Rs m5,2135,038 103.5%  
Depreciation Rs m1,5731,426 110.3%   
Interest Rs m1,8031,012 178.2%   
Profit before tax Rs m3,0493,570 85.4%   
Minority Interest Rs m127-65 -194.5%   
Prior Period Items Rs m-276 -420.3%   
Extraordinary Inc (Exp) Rs m-3710-   
Tax Rs m689255 270.2%   
Profit after tax Rs m2,0893,257 64.2%  
Gross profit margin %16.511.3 146.2%  
Effective tax rate %22.67.1 316.4%   
Net profit margin %6.67.3 90.7%  
BALANCE SHEET DATA
Current assets Rs m35,94939,906 90.1%   
Current liabilities Rs m19,40218,423 105.3%   
Net working cap to sales %52.448.2 108.9%  
Current ratio x1.92.2 85.5%  
Inventory Days Days7190 78.6%  
Debtors Days Days12798 129.1%  
Net fixed assets Rs m34,47835,832 96.2%   
Share capital Rs m894553 161.7%   
"Free" reserves Rs m22,60130,370 74.4%   
Net worth Rs m28,63235,739 80.1%   
Long term debt Rs m27,45516,542 166.0%   
Total assets Rs m76,59179,522 96.3%  
Interest coverage x2.74.5 59.4%   
Debt to equity ratio x1.00.5 207.2%  
Sales to assets ratio x0.40.6 73.5%   
Return on assets %5.15.4 94.7%  
Return on equity %7.39.1 80.1%  
Return on capital %8.28.7 94.4%  
Exports to sales %48.111.6 414.8%   
Imports to sales %14.54.5 324.2%   
Exports (fob) Rs m15,1925,177 293.5%   
Imports (cif) Rs m4,5651,990 229.4%   
Fx inflow Rs m16,6127,589 218.9%   
Fx outflow Rs m5,2922,878 183.9%   
Net fx Rs m11,3204,711 240.3%   
CASH FLOW
From Operations Rs m717716 100.1%  
From Investments Rs m-22,284-8,182 272.4%  
From Financial Activity Rs m29,4882,543 1,159.7%  
Net Cashflow Rs m8,073-4,923 -164.0%  

Share Holding

Indian Promoters % 27.7 74.5 37.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 37.8 2.3 1,643.5%  
FIIs % 8.6 7.7 111.7%  
ADR/GDR % 0.0 0.1 -  
Free float % 25.9 15.4 168.2%  
Shareholders   56,241 67,757 83.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   MERCK LTD  STERLING BIOTECH  ASTRAZENECA PHARMA  AUROBINDO PHARMA  IPCA LABS  

Compare STRIDES SHASUN LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Weak Finish to the Week Post Vishal Sikka's Exit as CEO of Infosys(Closing)

Share markets in India witnessed selling pressure, led by slump in shares of Infosys Ltd. after Vishal Sikka resigned as chief executive officer of the country's second-largest software services exporter.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Aug 18, 2017 (Close)

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD 8-QTR ANALYSIS

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS